MTG1 Inhibitors
MTG1 Inhibitors operate by indirectly attenuating the functional activity of MTG1, which is intricately connected to the mitochondrial ribosome and dependent on ATP for its GTPase activity. Chemical compounds that disrupt mitochondrial electron transport and ATP production are particularly effective at decreasing MTG1 function. For instance, inhibitors that target various complexes of the electron transport chain, such as complex I, III, and IV, create an energy deficit within the mitochondria, consequently impeding the GTPase activity of MTG1. These inhibitors act by obstructing electron flow and hindering ATP synthesis, which is vital for MTG1's action. Similarly, compounds that impair ATP synthase or uncouple oxidative phosphorylation also contribute to the decline in mitochondrial energy levels, thus indirectly inhibiting MTG1. The commonality among these inhibitors is their capacity to create an unfavorable energy environment that diminishes the function of MTG1.
In addition to targeting the electron transport chain and ATP production, some inhibitors work by affecting mitochondrial protein synthesis, which is essential for maintaining MTG1's GTPase functionality. Antibiotics that bind to the mitochondrial ribosome can inhibit protein synthesis, indirectly impacting MTG1's association with the ribosome and its subsequent activity. Metal chelating agents can disrupt metal ion homeostasis, impinging on enzymes that are crucial for MTG1's function. Moreover, intercalating agents that interfere with mitochondrial DNA replication and transcription can compromise the synthesis of mitochondrial proteins necessary for MTG1 function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $259.00 | 41 | |
This compound inhibits mitochondrial complex I, leading to reduced ATP production. MTG1, being associated with the mitochondrial ribosome, relies on ATP for its GTPase activity; thus, inhibition of ATP synthesis indirectly decreases MTG1 function. | ||||||
Oligomycin | 1404-19-9 | sc-203342 sc-203342C | 10 mg 1 g | $149.00 $12495.00 | 18 | |
By binding to mitochondrial ATP synthase, oligomycin impairs ATP production. Since MTG1’s GTPase activity is dependent on the mitochondrial energy status, oligomycin can indirectly inhibit MTG1 by limiting its energy supply. | ||||||
Antimycin A | 1397-94-0 | sc-202467 sc-202467A sc-202467B sc-202467C | 5 mg 10 mg 1 g 3 g | $55.00 $63.00 $1675.00 $4692.00 | 51 | |
This substance inhibits mitochondrial complex III, disrupting electron transport and reducing ATP synthesis. Reduced ATP levels can indirectly lead to decreased MTG1 activity, as its function is energy-dependent. | ||||||
Carboxine | 5234-68-4 | sc-234286 | 250 mg | $21.00 | 1 | |
Carboxine inhibits succinate dehydrogenase in complex II of the electron transport chain, thereby decreasing ATP synthesis. This decrease in ATP availability can indirectly reduce the GTPase activity of MTG1. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $90.00 | 10 | |
Chloramphenicol inhibits mitochondrial protein synthesis by binding to the peptidyl transferase component of the mitochondrial ribosome. This can indirectly inhibit MTG1 by interfering with its association with the ribosome and subsequent GTPase activity. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
As a metal chelating agent, can disrupt metal ion homeostasis within mitochondria, affecting enzymes that require metal cofactors, including those associated with MTG1 function, thereby indirectly inhibiting the GTPase activity. | ||||||
FCCP | 370-86-5 | sc-203578 sc-203578A | 10 mg 50 mg | $94.00 $355.00 | 46 | |
FCCP uncouples oxidative phosphorylation by dissipating the proton gradient across the mitochondrial membrane, leading to decreased ATP synthesis. This would indirectly inhibit MTG1 by reducing the mitochondrial energy output necessary for its activity. | ||||||
Sodium azide | 26628-22-8 | sc-208393 sc-208393B sc-208393C sc-208393D sc-208393A | 25 g 250 g 1 kg 2.5 kg 100 g | $43.00 $155.00 $393.00 $862.00 $90.00 | 8 | |
Inhibits mitochondrial complex IV, thereby disrupting ATP production. The reduced availability of ATP indirectly inhibits the GTPase activity of MTG1 due to its reliance on mitochondrial-generated energy. | ||||||
Ethidium bromide | 1239-45-8 | sc-203735 sc-203735A sc-203735B sc-203735C | 1 g 5 g 25 g 100 g | $48.00 $150.00 $588.00 $2086.00 | 12 | |
As an intercalating agent, ethidium bromide inhibits mitochondrial DNA replication and transcription. This indirectly inhibits MTG1 by impacting the mitochondrial protein synthesis necessary for its function and association with the ribosome. | ||||||